Vitaflo International, Ltd
28
0
1
25
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
7.1%
2 terminated/withdrawn out of 28 trials
92.6%
+6.1% vs industry average
0%
0 trials in Phase 3/4
4%
1 of 25 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (28)
Evaluation of PKU Sphere in Italy
Role: lead
Evaluation of PKU UP
Role: lead
Evaluation of the Express Plus Range
Role: lead
Evaluation of PKU Sphere in Maternal PKU
Role: lead
Evaluation of TYR Sphere in France
Role: lead
Evaluation of PKU Explore France
Role: lead
The Effects of CGMP in Children and Adults With PKU
Role: lead
Ketogenic Diet for Patients Receiving Treatment for Metastatic Renal Cell Carcinoma
Role: collaborator
Protein Requirements in Adults With Phenylketonuria (PKU)
Role: collaborator
A Taste and Acceptance Study of FruitiVits in Children Aged 4-8 Years Following a Ketogenic Diet.
Role: lead
Evaluation of PKU Explore
Role: lead
Evaluation of TYR Sphere
Role: lead
Evaluation of PKU Sphere Liquid
Role: lead
Glycosade v UCCS in the Dietary Management of Hepatic GSD
Role: lead
Evaluation of PDE MAX
Role: lead
Evaluation of Renastep
Role: lead
A 16 Week Study Evaluating the Introduction of a GMP Based Protein Substitute in Participants With PKU
Role: lead
Evaluation of PKU Sphere
Role: lead
Evaluation of Keyo in Children With Epilepsy
Role: lead
Use of Betashot in Children and Adults With Epilepsy
Role: lead